Check out our most popular compounded medications! Get Started
Kojic Acid 4%/Triamcinolone Acetonide 0.5%/Betamethasone Dipropionate 0.064%/Tretinoin 0.05% Topical Gel is a specially compounded semisolid medication. It is dispensed through a pump mechanism for easy and precise application. This formulation is designed to target and treat skin conditions such as melasma, acne, hyperpigmentation, rosacea, and eczema.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This topical gel formulation is a compounded blend of Kojic Acid 4%, Triamcinolone Acetonide 0.5%, Betamethasone Dipropionate 0.064%, and Tretinoin 0.05%. It is a semisolid formulation dispensed through a pump mechanism, which facilitates easy and precise application on the skin for targeted treatment. The gel-like consistency allows for optimal absorption of the active ingredients.
The formulation is designed to treat a variety of skin conditions, including melasma, acne, hyperpigmentation, eczema, and psoriasis. Kojic Acid, a natural skin lightening agent, works to reduce the appearance of dark spots and discoloration. Triamcinolone Acetonide and Betamethasone Dipropionate, both corticosteroids, help to alleviate inflammation and itching. Tretinoin, a topical retinoid, aids in reducing the appearance of wrinkles and acne.
It is crucial to follow the instructions provided by your healthcare provider when using this formulation. If you have any questions or concerns, please do not hesitate to reach out to us at Bayview Pharmacy.
Kojic Acid 4%/Triamcinolone Acetonide 0.5%/Betamethasone Dipropionate 0.064%/Tretinoin 0.05% Topical Gel is a compounded formulation designed to address a range of skin conditions. This unique blend of active ingredients works synergistically to provide targeted treatment for conditions such as melasma, acne, hyperpigmentation, eczema, and psoriasis.
Kojic acid, a natural skin lightening agent, is included at a 4% concentration. It aids in reducing the appearance of dark spots and discoloration, promoting a more even skin tone. Triamcinolone acetonide and betamethasone dipropionate, both corticosteroids, are included at concentrations of 0.5% and 0.064% respectively. These ingredients work to reduce inflammation and itching associated with various skin conditions, providing relief and promoting healing.
Tretinoin, a topical retinoid, is included at a 0.05% concentration. It is known for its ability to reduce the appearance of wrinkles and acne, promoting smoother, clearer skin. This ingredient works by increasing the turnover of skin cells, helping to unclog pores and reduce the formation of acne lesions.
As with any medication, it is crucial to follow the directions provided by your healthcare provider to ensure safe and appropriate use. If you have any questions or concerns about this formulation or its use, it is recommended to consult with your healthcare provider or pharmacist.
Kojic Acid 4%/Triamcinolone Acetonide 0.5%/Betamethasone Dipropionate 0.064%/Tretinoin 0.05% Topical Gel is a compounded formulation designed to address a variety of skin conditions. This unique blend of active ingredients works synergistically to provide targeted treatment for your skin.
It works by inhibiting the production of melanin, the pigment responsible for skin color, thereby lightening the skin and improving its overall appearance.
Triamcinolone Acetonide and Betamethasone Dipropionate are corticosteroids that help reduce inflammation and itching associated with various skin conditions such as eczema and psoriasis. They work by suppressing the immune response, reducing inflammation and redness, and relieving itching and discomfort.
It promotes the turnover of skin cells, helping to unclog pores and reduce the appearance of fine lines and wrinkles. It also helps to lighten the skin by inhibiting melanin production.
To use this topical gel, apply a thin layer to the affected area once or twice daily, or as directed by your healthcare provider. Avoid contact with the eyes, mouth, and other mucous membranes. Be sure to wash your hands after applying the gel. If you experience any irritation or other side effects, discontinue use and contact your healthcare provider immediately.
If you have any questions about this formulation or its application, please don't hesitate to reach out. We are here to assist you in understanding and effectively using this compounded formulation for your skin health needs.
This compounded formulation is designed to treat various skin conditions. The active ingredients work together to lighten the skin, reduce inflammation, and promote skin cell turnover.
This gel should be applied directly to the skin. The pump mechanism allows for easy and precise application. Always follow your healthcare provider's instructions regarding how much to apply and how often.
This is a semisolid formulation with a gel-like consistency. It is designed to be easily absorbed by the skin for targeted treatment.
The active ingredients in this formulation are Kojic Acid, Triamcinolone Acetonide, Betamethasone Dipropionate, and Tretinoin.
Kojic Acid is used to lighten the skin. Triamcinolone Acetonide and Betamethasone Dipropionate are corticosteroids that reduce inflammation. Tretinoin promotes skin cell turnover.
This formulation is intended for topical use only. Avoid contact with eyes, mouth, and other mucous membranes. If you are unsure about where to apply the gel, consult your healthcare provider.
If you experience any side effects such as redness, irritation, or swelling, stop using the product and contact your healthcare provider immediately.
Store this product at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
If you are pregnant or breastfeeding, consult your healthcare provider before using this product. Some ingredients may be absorbed through the skin and could potentially affect the baby.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
